| Accession |
PRJCA002042 |
| Title |
Molecular mechanism of PARP inhibitor on BRCA1-related breast cancer therapy |
| Relevance |
Medical |
| Data types |
Whole genome sequencing
|
| Organisms |
Homo sapiens
|
| Description |
This work will provide the specific targets for the treatment of BRCA1-deficient breast cancer, as well as the scientific basis for designing new PARP inhibitors. |
| Sample scope |
Multiisolate |
| Release date |
2020-02-07 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| National Natural Science Foundation of China (NSFC)
|
General Program
|
81672610
|
Molecular mechanism of PARP inhibitor on BRCA1-related breast cancer therapy
|
|
|
| Submitter |
Mo
Li (limo@hsc.pku.edu.cn)
|
| Organization |
Peking University |
| Submission date |
2019-12-18 |
